Pramipexole dihydrochloride
- Product NDC
- 70934-596
- 11-digit product format
- 709340596
- Labeler code
- 70934
- Product ID
- 70934-596_ab9634bd-422a-2f73-e053-2995a90a802f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pramipexole dihydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA090781
- Marketing category
- ANDA
- Marketing start
- 2020-02-28
- Marketing end
- 0000-00-00
- Substance
- PRAMIPEXOLE DIHYDROCHLORIDE
- Active strength
- 0 mg/1
- Pharmacologic classes
- Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 70934-596 | D | Discontinued by firm | 2026-08-03 | ||
| excluded package | package | 70934-596 | 70934-596-30 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090781-001 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | AB | 2010-10-08 | |
| A090781-002 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | AB | RS | 2010-10-08 |
| A090781-003 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | AB | 2010-10-08 | |
| A090781-004 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | AB | 2010-10-08 | |
| A090781-005 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | AB | 2010-10-08 | |
| A090781-006 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.75MG | TABLET / ORAL | AB | 2015-09-11 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090781-001 | AB |
| A090781-002 | AB |
| A090781-003 | AB |
| A090781-004 | AB |
| A090781-005 | AB |
| A090781-006 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090781-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | AB | 2010-10-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090781-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | AB | RS | 2010-10-08 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090781-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | AB | 2010-10-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090781-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | AB | 2010-10-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090781-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | AB | 2010-10-08 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A090781-006 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.75MG | TABLET / ORAL | AB | 2015-09-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090781-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090781-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090781-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090781-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090781-005 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090781-006 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pramipexole dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | Glenmark Pharmaceuticals Inc., USA | 44c336d2-01d1-4f13-bad9-549cdc3505ec | 2025-12-30 | Warnings, Adverse reactions | 090781 ANDA090781 |
| Pramipexole dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 5e6f2187-a5cc-481e-b0a1-d38d3f92e822 | 2024-10-09 | Warnings, Adverse reactions | 090781 ANDA090781 |
FDA-Initiated Inactive NDC Indexing#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70934-596-30 | 70934059630 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-596-30) | 30 tablet | 2020-02-28 | 0000-00-00 | No | No | Current |